Literature DB >> 9727741

Phenotypic and genotypic variability in monozygotic triplets with Turner syndrome.

J Lespinasse1, C Gicquel, M Robert, Y Le Bouc.   

Abstract

Turner syndrome (TS) is a common disorder (1/2500 and 1/5000 female births) which is diagnosed at birth in approximately 20% of patients and during childhood (usually due to growth retardation) or later, (due to lack of pubertal development) for the remaining patients. Here we present a cytogenetic and molecular analysis of three monozygotic sisters. The diagnosis of TS was done for one of them (patient 1) who presented with a typical Turner phenotype. A first karyotype was established as normal and a second karyotype (carried out on 200 cells) revealed a 45,X/46,XX mosaicism with 6% of cells with a 45,X karyotype. Lymphocyte karyotype analysis showed the same mosaicism pattern for the two other sisters, one of them exhibiting only a mild (patient 2) and the other no clinical features of Turner syndrome (patient 3). Karyotype analysis was this time conducted on fibroblasts and showed that the 45,X/46,XX mosaicism pattern correlated with the clinical phenotype with 99, 43 and 3% of 45,X cells in patients 1, 2, and 3, respectively. These data suggest that different tissues other than lymphocytes should be subjected to a karyotype analysis when the observed genotype does not correlate with the clinical phenotype.

Entities:  

Mesh:

Year:  1998        PMID: 9727741     DOI: 10.1111/j.1399-0004.1998.tb03694.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  1 in total

1.  Sensitive quantification of mosaicism using high density SNP arrays and the cumulative distribution function.

Authors:  Thomas C Markello; Hannah Carlson-Donohoe; Murat Sincan; David Adams; David M Bodine; Jason E Farrar; Adrianna Vlachos; Jeffrey M Lipton; Arleen D Auerbach; Elaine A Ostrander; Settara C Chandrasekharappa; Cornelius F Boerkoel; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-12-24       Impact factor: 4.797

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.